Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".
作者信息
de Oliveira Luciana Mello, da Silva Dal Pizzol Tatiane
机构信息
Núcleo de Avaliação de Tecnologias em Saúde, Gerência de Ensino e Pesquisa, Grupo Hospitalar Conceição (GEP-GHC), Porto Alegre, Rio Grande do Sul, Brazil.
Programa de Pós-Graduação em Epidemiologia (PPGEPI), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil.
出版信息
J Med Toxicol. 2023 Jul;19(3):307-308. doi: 10.1007/s13181-023-00936-4. Epub 2023 Mar 29.
Abstract
摘要
相似文献
1
Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".关于“他克莫司与奈玛特韦/利托那韦（帕罗韦德™）的药物相互作用及苯妥英钠的处理”的评论
J Med Toxicol. 2023 Jul;19(3):307-308. doi: 10.1007/s13181-023-00936-4. Epub 2023 Mar 29.
2
Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".对关于“他克莫司与奈玛特韦/利托那韦（帕罗韦德™）药物相互作用通过苯妥英处理”评论的回复
J Med Toxicol. 2023 Jul;19(3):309. doi: 10.1007/s13181-023-00940-8. Epub 2023 Mar 29.
3
Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin.他克莫司与奈玛特韦/利托那韦（帕克洛维）的药物相互作用，并用苯妥英管理。
J Med Toxicol. 2023 Jan;19(1):45-48. doi: 10.1007/s13181-022-00922-2. Epub 2022 Dec 19.
4
Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion.药物相互作用导致他克莫司血药浓度高于治疗范围，用苯妥英诱导酶代谢进行治疗：病例系列及讨论。
Am J Health Syst Pharm. 2024 Jun 24;81(13):e345-e352. doi: 10.1093/ajhp/zxae032.
5
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT).新冠病毒感染者中奈玛特韦/利托那韦药物相互作用的管理：法国药理学和治疗学学会（SFPT）指南。
Therapie. 2022 Sep-Oct;77(5):509-521. doi: 10.1016/j.therap.2022.03.005. Epub 2022 Apr 20.
6
Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant.COVID-19 感染患儿在使用奈玛特韦/利托那韦（Paxlovid）治疗后，他的他克莫司水平升高。
Pediatr Nephrol. 2023 Apr;38(4):1387-1388. doi: 10.1007/s00467-022-05712-0. Epub 2022 Aug 19.
7
Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients - a case series with four patients.尼马曲韦/利托那韦治疗 SARS-CoV-2 阳性肾移植受者 - 四例病例系列。
BMC Nephrol. 2023 Apr 15;24(1):99. doi: 10.1186/s12882-023-03154-w.
8
Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series.尼马瑞韦/利托那韦联合他克莫司用于肺移植受者：一项单中心病例系列研究。
Transplantation. 2023 May 1;107(5):1200-1205. doi: 10.1097/TP.0000000000004394. Epub 2022 Oct 28.
9
Nirmatrelvir Plus Ritonavir: First Approval.奈玛特韦片/利托那韦片：首次获批。
Drugs. 2022 Apr;82(5):585-591. doi: 10.1007/s40265-022-01692-5.
10
Treatment of prolonged tacrolimus toxicity using phenytoin in a haemodialysis patient.血液透析患者使用苯妥英钠治疗环孢素 A 毒性延长。
J Clin Pharm Ther. 2019 Aug;44(4):640-643. doi: 10.1111/jcpt.12829. Epub 2019 Mar 4.
引用本文的文献
1
Pharmacokinetic Interactions of Paxlovid Involving CYP3A Enzymes and P-gp Transporter: An Overview of Clinical Data.帕罗韦德与CYP3A酶和P-糖蛋白转运体的药代动力学相互作用：临床数据概述
Curr Drug Metab. 2024;25(9):639-652. doi: 10.2174/0113892002320326250123082112.
本文引用的文献
1
Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin.他克莫司与奈玛特韦/利托那韦（帕克洛维）的药物相互作用，并用苯妥英管理。
J Med Toxicol. 2023 Jan;19(1):45-48. doi: 10.1007/s13181-022-00922-2. Epub 2022 Dec 19.
2
Potential determinants of prescribers' drug-drug interaction knowledge.开处方者药物相互作用知识的潜在决定因素。
Res Social Adm Pharm. 2008 Dec;4(4):355-66. doi: 10.1016/j.sapharm.2007.10.004. Epub 2008 Aug 8.
3
Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.处方医生对潜在药物相互作用的了解及信息来源：对美国处方医生的邮寄调查。
Drug Saf. 2008;31(6):525-36. doi: 10.2165/00002018-200831060-00007.
Zotero 插件